Lipid peroxidation of rats’ heart with hypertension after nebivolol applying

  • R. S. Dovgan Bogomolets National Мedical University, Kyiv
  • V. A. Stezhka SI «Institute for Occupational Health of National Academy of Medical Sciences of Ukraine», Kyiv
  • I. S. Chekman Bogomolets National Мedical University, Kyiv
Keywords: arterial hypertension, rats, lipid peroxidation, nebivolol


A significant contribution to the study of the complex mechanisms of the action of beta-blockers may provide the investigation of structure of the heart – the main target organ of hypertension. Recent works have shown that beta-blockers such as carvedilol and bisoprolol, by the deacreasing of blood pressure, reduce adverse morphological changes in the myocardium of rats with spontaneous hypertension (ISIAH). Differences in the effects of various beta-blockers, which are marked in clinical trials are associated with their varying selectivity, sympathomimetic activity, solubility in fats, ability to metabolize in the liver, the duration of action.

By lipid peroxidation was investigated in 3 groups of animals (7 in each group): control (normotensive rats ), rats with ISIAH, ISIAH with rats treated with nebivolol dissolved in water in a dose of 1 mg/kg through gastral tube once a day during 60 days. Blood pressure was measured in the tail artery with a rubber cuff and plethysmograph without anesthesia at the beginning of the experiment and before the withdrawal of animals from the experiment.

Activity lipid peroxidation  investigated in mixed arterial-venous plasma and myocardial homogenates. For this registration spontaneous and Fe2+-induced superweak their glow (chemiluminescence) using hemilyuminometr.

Nebivolol statistically significantly had lowered blood pressure in rats with ISIAH till 137 ± 5.0 mm, compared with untreated animals 157 ± 5.0 mm, but did not reach control values 104 ± 1.8 mm. Pressure decrease was correlated with improvement of lipid peroxidation of rat hearts with ISIAH after application of nebivolol. The established difference in the activity of the lipid peroxidation in intact rats and animals hypertensive. In rats with hypertension rats activity of lipid peroxidation in the myocardium is higher compared with normotensive rats, whereas plasma reduced. Nebivolol in the application in rats ISIAH in the myocardium reduces the amount of peroxidation products of free radical reactions in comparison with the control group ISIAH lines. As a result of reduction of reactive oxygen species by reacting with free radicals. Nebivolol in the application within 60 days in rats ISIAH reduces the number of pro-oxidant in plasma.


1. Amosova E.N. Are β-blockers blocking first-line drugs for the treatment of arterial hypertension? // Heart and blood vessels. - 2013. - Vol. 42, No. 2. - P. 80-83.
2. Kovalenko V.M., Kornatsky V.M. Implementation of the State Program for Combating Hypertension in Ukraine // Ukr. cardiology journ - 2010. - No. 6. - P. 7-12.
3. European Society of Cardiology guidelines for the management of arterial hypertension // J. Hypertension. - 2007. - P. 25 - P. 1105.
4. Sirenko Yu. N. Modern strategy of antihypertensive therapy with fixed combinations // Arterial hypertension. - 2013. - No. 1 (27). - P. 52-56.
5. Dinicolantonio J. J., Lavie C. J., Fares H. Meta-analysis of carvedilol versus beta1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol) // Am. J. Cardiol - 2013. - Vol. 111. - P. 765-769.
6. Michels R., Kraszna K., Mkel W. Nebivolol inhibition of coronary artery smooth muscle cell proliferation after percutaneous coronary artery intervention. Results of the NESCIO Study, a randomized double blind trial // Eur. Rev. Med. Pharmacol Sci - 2011. - V. 15, N 11. - P. 1264-1269.
Weiss R. J., Weber M. A., Carr A. A. et al. A randomized, double-blind, placebo-controlled parallel-group study to evaluate the efficacy and safety of nebivolol, a novel β-blocker, in patients with mild to moderate hypertension, J. Clin. Hypertens - 2007. - V. 9. - P. 667-676.
8. Zakaryan AE, Zakaryan Z. A., Trchunyan AA Different Methods of Chemiluminescent Analysis in the Assessment of the Level of Free Radical Peroxide Oxidation of Human Serum Lipoproteins in the Development of Pathological Processes in the Body // Reports of the National Academy of Sciences of Armenia. - 2012. - Vol. 112, No. 1, - P. 79-86.
9. Meshkov I.O., Alekhina T.A., Moreva T.A., Markel A.L. Characteristics of the behavior of hypertensive rats of the NISAG line // Journal. higher nervous activity by them. I.P. Pavlova. - 2012. - No. 2. - P. 233-242.
10. Chekman I. S., Gorchakova N. O., Nagorna O. O. Experimental Models of Arterial Hypertension // Pharmacol. cure toxicologist - 2012. - No. 3. - P. 10-20.
11. Stechko L. O., Chukhray S. M., Dovgan R. S. Ultrastructure of endothelial cells of blood capillaries of cardiac myocardium in rats with spontaneous arterial hypertension // Vysn. morphology - 2010. - T. 16, No. 1. - P. 113-116.
12. Debold E. P., Saber W., Cheema Y. et al. Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro // J. Mol. Cell Cardiol - 2010. - V. 48, N 2. - P. 286-292.
13. Maddala R., Nagendran T., de Ridder G. G. et al. L-type calcium channels play a critical role in maintaining lens transparency by regulating the phosphorylation of aquaporin - 0 and myosin light chain and expression of connexins // PLoS One. - 2013. - V. 8, N 5. - P. 664-676.
14. Mahata M., Zhang K., Gayen J. R. et al. Catecholamine biosynthesis and secretion: physiological and pharmacological effects of secretin // Cell Tissue Res. - 2011. - V. 345, N 1. - P. 87-102.
15. Maffei A., Di Pardo A., Carangi R. et al. Nebivolol induces nitric oxide release in the heart via inducible nitric oxide synthase activation // Hypertension. - 2007. - V. 50. - P. 652-656.
16. Seddon M., Shah A. M., Casadei B. Cardiomyocytes as Effects of Nitric Oxide Signaling // Cardiovasc. Res - 2007. - V. 75, N 3. - P. 315-326.
17. Strasen J., Ritter O. Role of NOS in cardiac ischemia - reperfusion injury // Trends Cardiovasc. Med. - 2011. - V. 21, N 2. - P. 58-63.
18. Tamargo J., Caballero R., Gómez R. et al. Cardiac electrophysiological effects of nitric oxide // Cardiovasc. Res - 2010. - V. 87, N 4. - P. 593-600.
19. Zvyagina V.I., Medvedev D.V., Belsky E. S. et al. Effect of a donor of nitric oxide l - arginine on the activity of mitochondrial oxidoreductases and oxidative processes in rats' heart tissue under conditions of nitrogen oxide deficiency // Fundamental research. - 2013. - № 8. - p. 1087-1091.
20. Mason RP, Kubant R., Jacob R. F. et al. Effect of nebivolol on the release of endothelial nitric oxide and peroxynitri in hypertensive animals: the role of antioxidant activity // J. Cardiovasc. Pharmacol - 2006. - P. 48. - P. 862-869.
How to Cite
Dovgan, R. S., Stezhka, V. A., & Chekman, I. S. (2019). Lipid peroxidation of rats’ heart with hypertension after nebivolol applying. Farmatsevtychnyi Zhurnal, (3), 88-94. Retrieved from
General and Clinical Pharmacology